Reduced cytochrome P450 and increased heme oxygenase in liver during rabbit aflatoxicosis.
The administration of aflatoxin B1 (AFB1) in New Zealand rabbit for 5 days at a daily oral dose of 0.05 or 0.1 mg/kg decreased microsomal hepatic cytochrome P450 whereas a dose-dependent increase in the reduced microsomal 420 nm absorption occurred. The nature of such an absorption was then investigated. Either in vitro incubation of control microsomal proteins with AFB1 up to 800 microM and NADPH, or primary rabbit hepatocyte cultures exposure to AFB1 up to 30 microM for 24 to 72 h, failed to produce any 420 nm absorbing species, suggesting that the 420 nm absorption observed in vivo was due to an hemoprotein increase. Chemical reductions of microsomal proteins from AFB1-treated rabbits confirmed this hypothesis. Enzyme activity determinations revealed an increase in both microsomal heme oxygenase and NADPH-cytochrome c reductase activities in AFB1 treated rabbits, suggesting that the 420 nm absorption observed in vivo was related to a particular increase in heme oxygenase.
Guerre
P
P
Unité associée I.N.R.A. de Physiopathologie et Toxicologie expérimentales, E.N.V.T., Toulouse, France.
Larroque
C
C
Pineau
T
T
Burgat
V
V
Galtier
P
P
D000818:Animals; D002478:Cells, Cultured; D065607:Cytochrome P-450 Enzyme Inhibitors; D003580:Cytochromes / Q000378:metabolism; D004789:Enzyme Activation; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism*; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D015651:Mycotoxicosis / Q000201:enzymology; D011817:Rabbits; D000096702:Aflatoxin Poisoning
D065607:Cytochrome P-450 Enzyme Inhibitors; D003580:Cytochromes; D006419:Heme Oxygenase (Decyclizing); C013464:cytochrome P420